Details of the Drug

General Information of Drug (ID: DMF38M5)

Drug Name
4-Bromo-N-hydroxy-benzamide
Synonyms
4-Bromo-N-hydroxybenzamide; 4-Bromo-N-hydroxy-benzamide; 1836-27-7; CHEMBL351337; 4-bromobenzenecarbohydroxamic acid; p-Bromobenzohydroxamic acid; AC1LCOKZ; N-Hydroxy-4-bromobenzamide; p-bromophenylhydroxamic acid; 4-Bromo-N-hydroxybenzamide #; SCHEMBL8575405; Benzamide, 4-bromo-N-hydroxy-; CTK0E2598; DTXSID20345349; VESPFSJNQMGUCQ-UHFFFAOYSA-N; MolPort-002-985-506; ZINC5249551; STK249669; BDBM50015106; AKOS000175576; MCULE-4510290140; DA-16649; SC-53612; KB-290158; ST51029575; FT-0708429
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 216.03
Logarithm of the Partition Coefficient (xlogp) 1
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C7H6BrNO2
IUPAC Name
4-bromo-N-hydroxybenzamide
Canonical SMILES
C1=CC(=CC=C1C(=O)NO)Br
InChI
InChI=1S/C7H6BrNO2/c8-6-3-1-5(2-4-6)7(10)9-11/h1-4,11H,(H,9,10)
InChIKey
VESPFSJNQMGUCQ-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
603910
CAS Number
1836-27-7
TTD ID
D0J7AM

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Arachidonate 5-lipoxygenase (5-LOX) TT2J34L LOX5_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Arachidonate 5-lipoxygenase (5-LOX) DTT ALOX5 4.15E-01 -0.06 -0.15
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8.